The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations that the pharmacy benefit manager inflated drug prices, including for insulin, to boost ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, banning practices that favored high-priced drugs and requiring expanded access to lower-cost options. The deal is ...

The Maryland Supreme Court has vacated Baltimore’s $266 million opioid verdict and sent the case back to circuit court.

Site-neutral payment has advanced from E&M to drug administration codes, but stakeholders warn rapid, simultaneous policy ...

Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...

Democrat and Republican members alike criticized pharmacy benefit managers, who they say profit from driving up drug costs.

I think when you’re trying to regulate something that moves inherently faster than legislation ever could, it’s going to be a ...

Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...

President Donald Trump has announced a deal with Regeneron to lower the cost of its pharmaceutical products. The agreement, ...

PHOENIX — Unable to get traction on her 2024 controversial plan to cap drug prices, Gov. Katie Hobbs is now pursuing an alternate approach: a state-issued discount card. An executive order signed ...

UnitedHealth updated its full-year 2026 EPS guidance to greater than $18.25 per share, reflecting confidence in its ongoing strategic initiatives. The company continues to focus on AI investments and ...